Immune and non-immune functions of the immunoproteasome

被引:110
作者
Angeles, Arkhjamil [1 ]
Fung, Gabriel [1 ]
Luo, Honglin [1 ]
机构
[1] Univ British Columbia, St Pauls Hosp, UBC James Hogg iCAPTURE Ctr, Inst Heart & Lung Hlth,Dept Pathol & Lab Med, Vancouver, BC V6Z 1Y6, Canada
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2012年 / 17卷
基金
加拿大健康研究院;
关键词
Immunoproteasome; MHC class I antigen presentation; Oxidative stress; Cytokine production; T cell differentiation/survival; Cancer; Autoimmune diseases; Review; MAJOR HISTOCOMPATIBILITY COMPLEX; UBIQUITIN-PROTEASOME PATHWAY; MOLECULAR-MASS POLYPEPTIDE-2; T-CELL REPERTOIRE; 20 S PROTEASOME; INTERFERON-GAMMA; MULTIPLE-MYELOMA; UP-REGULATION; PEPTIDASE ACTIVITIES; SELECTIVE INHIBITOR;
D O I
10.2741/4027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biological importance of the ubiquitin-proteasome system in the control of myriad cellular processes has been well-recognized; however, the pathophysiological significance of the immunoproteasome, the inducible form of the proteasome, has not been well-comprehended until lately. The primary function of the immunoproteasome was originally believed to improve MHC-I antigen presentation. It now becomes evident that the immunoproteasome possesses broader biological functions. It regulates proinflammatory cytokine production, and T cell differentiation and proliferation. Alongside immune functions, the immunoproteasome has been demonstrated to relieve oxidative stress by the efficient turnover of oxidatively-damaged proteins and by allaying the formation of harmful protein aggregates. Furthermore, it has been implicated to regulate tumor cell growth and control muscle mass. Finally, the immunoproteasome has recently drawn considerable attention as a potential novel therapeutic target for cancer and autoimmune disease. This review will give an overview of the structure and function of the immunoproteasome, highlight its functional diversity in both immune and non-immune responses, and discuss the relationship between the dysregulation of the immunoproteasome and the development of several human diseases. (Words: 174)
引用
收藏
页码:1904 / 1916
页数:13
相关论文
共 88 条
[1]   The development of proteasome inhibitors as anticancer drugs [J].
Adams, J .
CANCER CELL, 2004, 5 (05) :417-421
[2]   INTERFERON-GAMMA INDUCES DIFFERENT SUBUNIT ORGANIZATIONS AND FUNCTIONAL DIVERSITY OF PROTEASOMES [J].
AKI, M ;
SHIMBARA, N ;
TAKASHINA, M ;
AKIYAMA, K ;
KAGAWA, S ;
TAMURA, T ;
TANAHASHI, N ;
YOSHIMURA, T ;
TANAKA, K ;
ICHIHARA, A .
JOURNAL OF BIOCHEMISTRY, 1994, 115 (02) :257-269
[3]   Effects of PS-341 on the activity and composition of proteasomes in multiple myeloma cells [J].
Altun, M ;
Galardy, PJ ;
Shringarpure, R ;
Hideshima, T ;
LeBlanc, R ;
Anderson, KC ;
Ploegh, HL ;
Kessler, BM .
CANCER RESEARCH, 2005, 65 (17) :7896-7901
[4]   Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection [J].
Barton, LF ;
Cruz, M ;
Rangwala, R ;
Deepe, GS ;
Monaco, JJ .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3046-3052
[5]   An altered T cell repertoire in MECL-1-deficient mice [J].
Basler, Michael ;
Moebius, Jacqueline ;
Elenich, Laura ;
Groettrup, Marcus ;
Monaco, John J. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (11) :6665-6672
[6]   Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome [J].
Basler, Michael ;
Dajee, Maya ;
Moll, Carlo ;
Groettrup, Marcus ;
Kirk, Christopher J. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (01) :634-641
[7]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[8]   The proteasome [J].
Bochtler, M ;
Ditzel, L ;
Groll, M ;
Hartmann, C ;
Huber, R .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1999, 28 :295-+
[9]   γ-interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation [J].
Bose, S ;
Brooks, P ;
Mason, GGF ;
Rivett, AJ .
BIOCHEMICAL JOURNAL, 2001, 353 :291-297
[10]   Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency [J].
Cai, Zheqing P. ;
Shen, Zhenyun ;
Van Kaer, Luc ;
Becker, Lewis C. .
FASEB JOURNAL, 2008, 22 (12) :4248-4257